Quest Diagnostics (DGX) Equity Ratio (2009 - 2026)

Quest Diagnostics has disclosed Equity Ratio across 18 years of filings, most recently posting 0.46 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.46, up 4.33% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46 (up 4.33% YoY), and the FY2025 annual result was 0.44, up 4.77% from the prior year.
• Equity Ratio came in at 0.46 for Q1 2026 at Quest Diagnostics, up from 0.44 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.48 in Q2 2022 to a low of 0.42 in Q4 2024.
• The 5-year median for Equity Ratio is 0.46 (2022), against an average of 0.46.
• Across the five-year window, Equity Ratio retreated 11.34% in 2024 and increased 5.43% in 2025, its largest moves.
• Quest Diagnostics' Equity Ratio stood at 0.46 in 2022, then dropped by 2.09% to 0.45 in 2023, then fell by 6.75% to 0.42 in 2024, then rose by 4.77% to 0.44 in 2025, then advanced by 4.04% to 0.46 in 2026.
• The last three Equity Ratio figures came in at 0.46 (Q1 2026), 0.44 (Q4 2025), and 0.45 (Q3 2025), per Business Quant data.